輸入代號或公司名稱後按 Enter
1762

中化生

-1.05 (-3.02%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
33.70151成交張數本益比0.81股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.75-0.920.4213.6%1.30%-1.60%
2026Q11.641161.5%-2.880.9125.1%2.89%-4.90%
2025Q4-2.55-1080.8%-4.39-1.41-124.5%-4.48%-7.57%
2025Q3-0.76-1.58-0.43-27.6%-1.32%-3.14%
2025Q2-1.21-548.1%-0.92-0.67-19.6%-2.03%-2.08%
2025Q10.13-75.0%0.560.073.8%0.22%0.59%
2024Q40.26-54.4%0.95-0.00-0.1%-0.01%1.58%
2024Q3-0.10-162.5%1.26-0.08-2.4%-0.25%2.94%
2024Q20.27-28.9%1.520.214.6%0.63%3.53%
2024Q10.52-77.5%1.630.4116.1%1.21%3.72%
2023Q40.57-36.7%3.420.449.7%1.33%8.10%
2023Q30.16-89.7%3.750.123.5%0.36%9.06%
2023Q20.38-80.0%5.150.305.6%0.88%12.66%
2023Q12.3140.0%6.671.7923.4%5.43%16.22%
2022Q40.90-23.7%6.010.7012.8%2.21%15.31%
2022Q31.5643.1%6.291.2125.9%3.96%16.54%
2022Q21.9016.6%5.821.4825.5%4.96%15.60%
2022Q11.6529.9%5.551.2824.1%4.35%15.37%
2021Q41.18-7.1%5.170.9118.0%3.21%14.86%
2021Q31.09142.2%5.260.8516.8%3.04%15.70%
2021Q21.63-65.9%4.621.2625.3%4.66%13.81%
2021Q11.27252.8%7.770.9823.3%3.83%25.79%
2020Q41.27164.6%6.860.9917.6%4.02%23.57%
2020Q30.4536.4%6.070.3412.1%1.44%21.48%
2020Q24.782711.8%5.953.7194.7%16.79%21.32%
2020Q10.36-32.1%1.340.289.0%1.37%5.09%
2019Q40.481.510.3713.4%1.85%5.85%
2019Q30.33-88.3%0.980.2511.8%1.30%3.77%
2019Q20.17-10.5%3.480.134.2%0.68%14.38%
2019Q10.53960.0%3.500.4111.9%2.05%14.08%
2018Q4-0.05-108.1%3.02-0.04-1.8%-0.20%12.31%
2018Q32.83253.8%3.692.20123.3%11.40%14.99%
2018Q20.191.660.154.5%0.82%7.31%
2018Q10.051.310.041.3%0.20%5.65%
2017Q40.6267.6%1.110.4813.9%2.66%4.78%
2017Q30.80344.4%0.860.6217.3%3.57%3.80%
2017Q2-0.160.24-0.12-6.3%-0.70%1.08%
2017Q1-0.15-165.2%0.40-0.12-4.4%-0.67%1.71%
2016Q40.370.780.299.5%1.63%
2016Q30.180.144.2%0.80%